At the heart of Hato Rey Pathology (HRP) Labs in Puerto Rico, Luis Ferrer Torres leads with a clear mission: to deliver timely, precise, and personalized diagnostic services that put patients first. As Director of the Immunopathology Division, Ferrer brings decades of experience and a deep commitment to advancing pathology in a region where logistical challenges often complicate healthcare delivery.
Here, he discusses the importance of self-sufficiency, preparedness, and strategic partnerships for success in a setting where resources can be unreliable.
Meet Luis Ferrer Torres
Reflecting on his journey into medicine, Ferrer shares, “I wanted to become a physician as long as I can remember.” His interest in pathology was piqued by television series featuring medical examiners. “But it was during my time in medical school,” he says, “that I realized pathologists are also physicians and play a vital role in the medical field.” This discovery marked a turning point in his career and shaped his commitment to the discipline.
When asked about a defining moment that reaffirmed his chosen path, Ferrer recalls, “The first tumor board that I participated in cemented my commitment to patient-centered care.” He notes that the pathologist’s input is essential, stating, “The pathologist plays a principal role in determining patient management and care.”
Addressing common perceptions about pathology, Ferrer says, “I have never felt that I work behind the scenes. For me, the role of the pathologist is main stage in the management of patients.”
Time counts, especially on an island
HRP’s approach to pathology adopts the three-tiered approach of diagnostic, prognostic, and predictive insights to personalize patient care. However, operating in Puerto Rico presents unique challenges. “We are an island,” Ferrer notes, “and that means we must be self-sufficient.” Shipping delays, insurance restrictions, and the perishability of certain specimens make in-house testing not just preferable, but essential.
Advanced pathology tools have made a significant impact across all fields of pathology in Puerto Rico, with a particularly notable effect on cancer care. Alongside the introduction of molecular tests, automation of elements of the diagnostic workflow has also made a big impact in this area.
The introduction of automated histology staining has been transformative — boosting efficiency, reducing costs, and improving turnaround times. “Having instruments like the Dako Omnis in-house allows us to process cases immediately and deliver the diagnostic results to clinicians the same day — or by the next day if cases are run overnight. That speed is critical for patients awaiting a diagnosis and for clinicians planning treatment,” says Ferrer.
Cutting the red tape
One of the most pressing challenges facing healthcare infrastructure in Puerto Rico today is the influence of managed care health insurance companies. These companies often dictate which laboratory tests can be performed, basing their decisions on protocols that are “not necessarily clinically validated,” as Ferrer points out.
To address this, HRP Labs employs dedicated personnel who interact directly with insurance companies, working to ensure they understand the medical necessities and prioritize the benefit of the patient. HRP’s approach is rooted in clinically approved protocols and recommendations, ensuring that patient care is not compromised by administrative hurdles.
Expecting the unexpected
Preparedness is another priority: HRP Labs has taken proactive steps to maintain operations during natural disasters such as hurricanes and earthquakes, which can severely disrupt healthcare services on the island.
Ferrer explains, “We have installed an emergency infrastructure that can function after a natural disaster, maintaining a continuous workflow even after such an event.” This resilience ensures that laboratory services remain available when they are needed most.
Putting patients first
When hiring new pathologists or laboratory staff, Ferrer looks for individuals who demonstrate preparation, dedication to patients, and a strong work ethic. He is candid about the demands of practicing pathology in Puerto Rico, noting that it requires extra work and hours because of the case load. “I don’t sugar coat their duties and responsibilities,” he affirms. “There will be times when our compromise with the patients will have to come first.”
To medical students considering a career in pathology, Ferrer offers enthusiastic encouragement: “Go for it! Pathology is a fulfilling and exciting specialty of medicine that needs more physicians to pursue it.”
Global expertise, local impact
Ferrer attributes much of the success of HRP Labs to strong partnerships with the diagnostics industry. “For laboratories considering a partnership with a vendor,” he says, “look for a company that listens, adapts, and shares your values. For us, that means a global company with a grounded attitude, that cares about patients like we do.”
“Using Agilent’s instruments and biomarkers, we can quickly perform the diagnostic and predictive tests essential for patient care,” says Ferrer. This capability has helped HRP Labs deliver timely, accurate results that directly impact treatment decisions and patient outcomes.
“We need partners that understand our regional needs – adapting pricing, support, and solutions to fit our reality,” Ferrer explains. He recalls a recent example: “I suggested an improvement to an instrument, and within 24 hours, I was speaking with experts from Europe and the US. That made me feel like part of the team.”
He adds, “Everyone in the lab – from technicians to pathologists – must be focused on one thing: the patient. And I want our partners to do the same.”
Maintaining the momentum
Regarding long-term strategic objectives, Ferrer articulates a commitment to expanding HRP Labs’ molecular diagnostic capabilities, recognizing this initiative as essential for advancing patient care and maintaining the institution’s role at the forefront of innovation.
He anticipates significant changes in the practice of pathology over the next five to ten years, particularly within underserved and remote communities. “Advances in digital pathology, supplemented by artificial intelligence, will transform the delivery of timely and accurate diagnostics irrespective of geographic location,” he predicts.
HRP Labs is positioned to continue its leadership in the field by adopting innovative technologies while upholding a human-centered approach. Ferrer concludes, “We’re not just looking at slides. We’re looking at patient lives.”
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
